Teva

Teva collaborates on skin disease treatment, releases targets

Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo

Logo of Teva Pharmaceutical
Logo of Teva Pharmaceutical

Teva seeks startups to help solve global pharmaceutical challenges

The Resilience Acceleration program in Teva’s offices

Placing the focus on the therapist

 Illustrative photo shows various medicine pills in their original packaging

Does a common heart attack pill help everyone? Studies disagree


NYSE gala honors Pfizer, Teva Pharmaceuticals, Silverstein Properties, Azrieli Group

Israel Day, organized and hosted by the America-Israel Friendship League and Israeli Mapped in NY annually holds the event in collaboration with the NY Stock Exchange to honor Israeli tech

 Pfizer, Teva Pharmaceuticals, Silverstein Properties and Azrieli Group Honored by the America Israel Friendship League (AIFL)  at its Annual Gala

Teva to pay $523m. to New York as it looks to move past opioid lawsuits

Teva Pharmaceutical Industries will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the US opioid epidemic.

 Teva building in Kfar Saba

Israel's Teva pharmaceuticals company keeps selling to Russia despite sanctions

Teva CEO Kare Schultz said that despite sanctions, Teva still sells medications to Russia, because this is a humanitarian move. He also revealed that Teva donates medicines to Ukraine.

 Teva building in Kfar Saba

Israel's Teva Pharm to start paying US opioid settlement in 2023, says CEO

The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.

 The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019.

CVS, Walmart, Walgreens ordered to pay $650.6m. in Ohio in opioid case

The litigation has resulted in several nationwide settlements, including a $4.25 billion settlement with Israel-based Teva Pharmaceutical Industries

The steep rise in opioid use here is a real danger to public health

AION, aMoon up for top scientific innovation award

AION Labs brings together some of the biggest names in pharma, including AstraZeneca, Merck and Pfizer, and aMoon is Israel’s largest health-tech fund.

AION Labs CEO Mati Gil.

Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits

The US opioid crisis has caused more than 500,000 overdose deaths over the past two decades, including more than 80,000 in 2021 alone.

 Teva building in Kfar Saba

Grapevine: Screaming sumo

Movers and shakers in Israeli society.

 Teva building in Kfar Saba

Teva, Allergan reach $161.5 million opioid settlement with West Virginia

The agreement is the largest state-negotiated settlement in West Virginia history and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

State sues Teva over Copaxone drug royalties

Two doctors sued Teva for failing to acknowledge their contributions and demanded to be compensated with royalties stemming from the new version of copaxone.

Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020